Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-48,400
Closed -$2.9M 722
2017
Q2
$2.9M Buy
48,400
+13,800
+40% +$891K 0.1% 239
2017
Q1
$2.29M Sell
34,600
-13,700
-28% -$959K 0.06% 301
2016
Q4
$3.41M Buy
48,300
+25,200
+109% +$1.57M 0.12% 229
2016
Q3
$1.37M Buy
23,100
+5,800
+34% +$284K 0.03% 321
2016
Q2
$722K Buy
+17,300
New +$621K 0.02% 389
2014
Q4
Sell
-25,500
Closed -$851K 538
2014
Q3
$851K Buy
25,500
+2,100
+9% +$77K 0.03% 394
2014
Q2
$872K Buy
+23,400
New +$702K 0.04% 376
2014
Q1
Sell
-12,200
Closed -$336K 585
2013
Q4
$336K Buy
+12,200
New +$285K 0.02% 433

Other funds holding AGX

Hutchin Hill Capital's AGX Position: Q3 2017 in Review

Hutchin Hill Capital sold out of Argan (AGX) in Q3 2017, closing a stake of 48,400 shares — an estimated $2.9M sold.

Hutchin Hill Capital first reported a position in AGX in Q4 2013 and held it in 8 quarters. The position peaked at $3.41M in Q4 2016. 184 funds tracked by Wall St. Rank hold AGX as of Q3 2017.

  • Hutchin Hill Capital reported no remaining Argan position as of Q3 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 48,400 Argan shares in Q3 2017, an estimated $2.9M.
  • Hutchin Hill Capital first reported a position in Argan in Q4 2013 and held it in 8 quarters.
  • Hutchin Hill Capital's Argan position peaked at $3.41M in Q4 2016.
  • 184 funds tracked by Wall St. Rank held Argan as of Q3 2017.

Based on Hutchin Hill Capital's 13F filing for Q3 2017, filed 14 Nov 2017.